|
WARDS
|
|
Drug
|
Isolates tested
|
% Not
susceptible
|
%R
|
%I
|
| Piperacillin |
65
|
23,08%
|
23,08%
|
0,00%
|
| Piper/Tazo |
88
|
17,05%
|
17,05%
|
0,00%
|
| Ticarcillin |
64
|
39,06%
|
39,06%
|
0,00%
|
| Ticar/Clav |
78
|
35,90%
|
35,90%
|
0,00%
|
| |
|
|
|
|
| Ceftazidime |
114
|
34,21%
|
28,95%
|
5,26%
|
| Aztreonam |
95
|
46,32%
|
36,84%
|
9,47%
|
| |
|
|
|
|
| Cefepime |
82
|
31,71%
|
20,73%
|
10,98%
|
| |
|
|
|
|
| Imipenem |
107
|
28,04%
|
25,23%
|
2,80%
|
| |
|
|
|
|
| Gentamicin |
114
|
41,23%
|
29,82%
|
11,40%
|
| Tobramycin |
110
|
32,73%
|
26,36%
|
6,36%
|
| Amikacin |
113
|
29,20%
|
29,20%
|
0,00%
|
| Netilmicin |
66
|
34,85%
|
28,79%
|
6,06%
|
| |
|
|
|
|
| Ciprofloxacin |
111
|
39,64%
|
33,33%
|
6,31%
|
|
|
|
ICU
|
|
Isolates tested
|
% Not
susceptible
|
%R
|
%I
|
|
41
|
56,10%
|
56,10%
|
0,00%
|
|
55
|
47,27%
|
47,27%
|
0,00%
|
|
43
|
74,42%
|
74,42%
|
0,00%
|
|
44
|
79,55%
|
79,55%
|
0,00%
|
|
|
|
|
|
|
72
|
61,11%
|
56,94%
|
4,17%
|
|
70
|
72,86%
|
54,29%
|
18,57%
|
|
|
|
|
|
|
55
|
61,82%
|
52,73%
|
9,09%
|
|
|
|
|
|
|
73
|
61,64%
|
47,95%
|
13,70%
|
|
|
|
|
|
|
72
|
66,67%
|
51,39%
|
15,28%
|
|
69
|
62,32%
|
62,32%
|
0,00%
|
|
72
|
48,61%
|
41,67%
|
6,94%
|
|
35
|
51,43%
|
42,86%
|
8,57%
|
|
|
|
|
|
|
71
|
69,01%
|
66,20%
|
2,82%
|
|
